Centro Multidisciplinar de Estudos Clinicos

São Bernardo do Campo, São Paulo 09715-090

0 studies enrolling now · 4 studies all time

What they study most

Crohn's Disease, Discoid Lupus Erythematosus, Obesity, Overweight, Overweight or Obesity, Type 2 Diabetes

Studies at this site

• Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus — Stopped early
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling
• A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities — Running, not enrolling
• A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor — Completed